GROUPE SANTE DEVONIAN INC has a total of 17 patent applications. It decreased the IP activity by 25.0%. Its first patent ever was published in 2011. It filed its patents most often in EPO (European Patent Office), United States and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are KADE PHARMA FAB GMBH, HARBIN OT PHARMACEUTICALS CO and NANO EGG KK.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | United States | 5 | |
#3 | Canada | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | China | 1 | |
#6 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology | |
#4 | Biotechnology | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Syringes | |
#4 | Specific use of cosmetics | |
#5 | Heterocyclic compounds | |
#6 | Organic chemistry methods | |
#7 | Microorganisms | |
#8 | Special foods | |
#9 | Foods |
# | Name | Total Patents |
---|---|---|
#1 | Boucher Nathalie | 13 |
#2 | Gana Theophilus J | 9 |
#3 | Boulet Andre P | 8 |
#4 | Boulet André P | 8 |
#5 | Maes Paul | 3 |
#6 | Purcell Marc | 1 |
#7 | Drouin Réjean | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020237383A1 | Thylakoids as delivery system for cannabinoïds and other molecules and formulations thereof | |
US2019314433A1 | Composition for the Prevention and/or Treatment of Cardiovascular Diseases | |
EP3389684A1 | Extraction and process for active thylakoid membranes | |
US2018311293A1 | Thylakoid extract composition and formulation for the treatment of inflammatory bowel disease | |
EP2558062A1 | The use of a photosynthetic cell extract comprising functional thylakoids in cosmetic compositions |